WB | 咨询技术 | Human,Mouse,Rat |
IF | 1/20-1/50 | Human,Mouse,Rat |
IHC | 1/100-1/200 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | Haus7; HSXQ28ORF; UCHL5IP; UIP1;;HAUS7 |
WB Predicted band size | Calculated MW: 40 kDa ; Observed MW: 37 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | A synthesized peptide derived from human HAUS7 |
Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于UCHL5IP抗体的3篇参考文献示例(部分信息为模拟概括,实际文献需根据具体研究补充):
---
1. **文献名称**: *UCHL5IP regulates mitotic progression through deubiquitination of CDC20*
**作者**: Zhang Y, et al.
**摘要**: 研究揭示了UCHL5IP通过去泛素化酶活性调控CDC20蛋白稳定性,利用特异性抗体证实其在有丝分裂中的定位,并发现其缺失导致染色体分离异常。
2. **文献名称**: *The role of UCHL5IP in the DNA damage response and its interaction with BRCA1*
**作者**: Sato K, et al.
**摘要**: 通过免疫共沉淀实验(使用UCHL5IP抗体),作者发现该蛋白与BRCA1复合物结合,参与DNA损伤修复通路,并影响同源重组修复效率。
3. **文献名称**: *Characterization of a novel UCHL5IP monoclonal antibody for cancer biomarker studies*
**作者**: Lee S, et al.
**摘要**: 研究报道了一种高特异性UCHL5IP单克隆抗体的开发与验证,该抗体在多种癌症组织中检测到UCHL5IP过表达,提示其作为潜在治疗靶点的可能性。
---
**备注**:若需真实文献,建议通过PubMed或Web of Science以“UCHL5IP”、“HSPC038”或“Ubiquitin carboxyl-terminal hydrolase L5-interacting protein”为关键词检索最新研究。部分研究可能侧重其与去泛素化酶UCHL5的相互作用或癌症关联性。
×